DOP2002000449A - Sal sodica de un inhibidor de integradasa del vih. - Google Patents
Sal sodica de un inhibidor de integradasa del vih.Info
- Publication number
- DOP2002000449A DOP2002000449A DO2002000449A DO2002000449A DOP2002000449A DO P2002000449 A DOP2002000449 A DO P2002000449A DO 2002000449 A DO2002000449 A DO 2002000449A DO 2002000449 A DO2002000449 A DO 2002000449A DO P2002000449 A DOP2002000449 A DO P2002000449A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- sodium salt
- hiv
- inhibitor
- integradasa
- compound
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- NOJNFULGOQGBKB-UHFFFAOYSA-M sodium;3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoate Chemical compound [Na+].C1=NC(OCC)=CC=C1C(C=C1)=CC=C1CN1C2=CC=C(OCC=3N=CC(C)=CC=3)C=C2C(SC(C)(C)C)=C1CC(C)(C)C([O-])=O NOJNFULGOQGBKB-UHFFFAOYSA-M 0.000 title 1
- 229940126062 Compound A Drugs 0.000 abstract 4
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 4
- 208000030507 AIDS Diseases 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 229940099797 HIV integrase inhibitor Drugs 0.000 abstract 1
- 239000003084 hiv integrase inhibitor Substances 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31337301P | 2001-08-17 | 2001-08-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2002000449A true DOP2002000449A (es) | 2003-05-15 |
Family
ID=23215462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2002000449A DOP2002000449A (es) | 2001-08-17 | 2002-08-15 | Sal sodica de un inhibidor de integradasa del vih. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6924282B2 (https=) |
| EP (1) | EP1430058A1 (https=) |
| JP (1) | JP2005501857A (https=) |
| AR (1) | AR036256A1 (https=) |
| CA (1) | CA2456206A1 (https=) |
| DO (1) | DOP2002000449A (https=) |
| WO (1) | WO2003016315A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2425440C (en) * | 2000-10-12 | 2010-04-13 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| WO2003077857A2 (en) * | 2002-03-15 | 2003-09-25 | Merck & Co., Inc. | N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
| CN100418948C (zh) * | 2003-07-15 | 2008-09-17 | 麦克公司 | 羟基吡啶cgrp受体抗拮抗剂 |
| US20070185007A1 (en) | 2003-09-19 | 2007-08-09 | Haolun Jin | Aza-quinolinol phosphonate integrase inhibitor compounds |
| EP1742642B1 (en) * | 2004-04-14 | 2008-10-15 | Gilead Sciences, Inc. | Phosphonate analogs of hiv integrase inhibitor compounds |
| KR20090077813A (ko) | 2006-09-29 | 2009-07-15 | 아이데닉스 파마슈티칼스, 인코포레이티드 | Ｈｉｖ 억제제로서의 거울상이성질체적으로 순수한 포스포인돌 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2632639B1 (fr) | 1988-06-09 | 1990-10-05 | Sanofi Sa | Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent |
| IL101860A0 (en) | 1991-05-31 | 1992-12-30 | Ici Plc | Heterocyclic derivatives |
| US5681832A (en) | 1995-02-17 | 1997-10-28 | The United States Of America As Represented By The Department Of Health And Human Services | Aroylaniline compounds, pharmaceutical compositions, and methods of using same to inhibit viral activity |
| US5945431A (en) | 1996-03-15 | 1999-08-31 | Biochem Therapeutics Incorporated | Cytomegalovirus inhibiting compounds |
| EP0927164A1 (en) * | 1996-09-10 | 1999-07-07 | PHARMACIA & UPJOHN COMPANY | 8-hydroxy-7-substituted quinolines as anti-viral agents |
| KR100567649B1 (ko) | 1996-09-25 | 2006-04-05 | 아스트라제네카 유케이 리미티드 | 혈관 내피 성장 인자와 같은 성장 인자의 효과를 억제하는 퀴놀린 유도체 |
| DE69828284T2 (de) | 1997-06-30 | 2005-12-08 | Nippon Kayaku K.K. | Naphthyridinderivate oder salze davon |
| PL338783A1 (en) | 1997-08-25 | 2000-11-20 | Neurogen Corp | Substituted 4-oxo-naphtyridin-3-carboxamides as ligands of cerebral gaba receptors |
| DE69831506T2 (de) | 1997-12-22 | 2006-06-29 | Pharmacia & Upjohn Co. Llc, Kalamazoo | 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe |
| US6306891B1 (en) | 1998-06-03 | 2001-10-23 | Merck & Co., Inc. | HIV integrase inhibitors |
| US6380249B1 (en) | 1998-06-03 | 2002-04-30 | Merck & Co., Inc. | HIV integrase inhibitors |
| US6262055B1 (en) | 1998-06-03 | 2001-07-17 | Merck & Co., Inc. | HIV integrase inhibitors |
| JP2003503386A (ja) | 1999-06-25 | 2003-01-28 | メルク エンド カムパニー インコーポレーテッド | １−（芳香族またはヘテロ芳香族置換）−３−（ヘテロ芳香族置換）−１，３−プロパンジオン類およびそれの使用 |
| US6730682B2 (en) | 2000-07-12 | 2004-05-04 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
| GB0017676D0 (en) | 2000-07-19 | 2000-09-06 | Angeletti P Ist Richerche Bio | Inhibitors of viral polymerase |
| CA2425440C (en) * | 2000-10-12 | 2010-04-13 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| EP1441734B1 (en) | 2001-10-26 | 2007-02-28 | Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. | Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| NZ533057A (en) | 2001-10-26 | 2005-11-25 | Angeletti P Ist Richerche Bio | N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
-
2002
- 2002-08-09 AR ARP020103023A patent/AR036256A1/es unknown
- 2002-08-13 CA CA002456206A patent/CA2456206A1/en not_active Abandoned
- 2002-08-13 EP EP02794880A patent/EP1430058A1/en not_active Withdrawn
- 2002-08-13 JP JP2003521237A patent/JP2005501857A/ja not_active Withdrawn
- 2002-08-13 WO PCT/US2002/025675 patent/WO2003016315A1/en not_active Ceased
- 2002-08-14 US US10/218,537 patent/US6924282B2/en not_active Expired - Fee Related
- 2002-08-15 DO DO2002000449A patent/DOP2002000449A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6924282B2 (en) | 2005-08-02 |
| AR036256A1 (es) | 2004-08-25 |
| WO2003016315A1 (en) | 2003-02-27 |
| JP2005501857A (ja) | 2005-01-20 |
| CA2456206A1 (en) | 2003-02-27 |
| US20030119823A1 (en) | 2003-06-26 |
| EP1430058A1 (en) | 2004-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN07215A1 (en) | Potassium salt of an hiv integrase inhibitor | |
| EA200400022A1 (ru) | Соединения и способы лечения или предупреждения инфекций flavivirus | |
| LV12719A (lv) | Benzoxazinones as inhibitors of hiv reverse transcriptase | |
| BR0316771A (pt) | Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica | |
| BR0309581A (pt) | Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c | |
| NO305478B1 (no) | Hydroksyetylaminosulfonamider som retrovirale proteasehemmere | |
| MX9403380A (es) | Inhibidores de proteasa de vih utiles para el tratamiento de sida. | |
| ES2125251T3 (es) | Inhibidores de la proteasa del vih. | |
| DK0749421T3 (da) | Sulfonamidderivater som aspartylproteaseinhibitorer | |
| DE60036961D1 (de) | Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1-piperazinpentanamide als hiv-proteasehemmer | |
| UY26380A1 (es) | Inhibidores de fab i | |
| CY1106801T1 (el) | Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα | |
| ES2051641B1 (es) | Procedimientos para la preparacion de compuestos derivados de tiourea. | |
| NO20063958L (no) | HIV integrase inhibitorer | |
| GEP20207190B (en) | Methods for treatment and prophylaxis of hiv and aids | |
| TW200603783A (en) | Non-nucleoside reverse transcriptase inhibitors | |
| UY27577A1 (es) | Inhibidores de la integrasa del vih | |
| ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
| AR029544A1 (es) | Composiciones y metodos para tratar infecciones bacterianas | |
| DOP2002000449A (es) | Sal sodica de un inhibidor de integradasa del vih. | |
| PT1140113E (pt) | Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos | |
| PH12022550983A1 (en) | Novel substituted condensed ring compound | |
| ES2096874T3 (es) | Inhibidor de la proteasa de hiv util para el tratamiento del sida. | |
| TW200716571A (en) | Heterocyclic reverse transcriptase inhibitors | |
| MX9700036A (es) | Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas. |